J45.5
Severe persistent asthma
Clinical Classification Guidelines
Medical Intelligence & Overview
Severe persistent asthma is a chronic respiratory condition characterized by ongoing airway inflammation, resulting in frequent symptoms and significant limitations in daily activities. It is classified under the ICD-10 code J45.5 and requires consistent management to control its severity and prevent complications. This form of asthma often involves symptoms that are difficult to manage with standard therapies alone, demanding a comprehensive treatment plan from healthcare providers.
Causes & Symptoms
Clinical Causes: Genetic predisposition to asthma and related allergic conditions Environmental factors such as exposure to cigarette smoke, air pollution, or occupational irritants Frequent respiratory infections that worsen airway inflammation Obesity, which can exacerbate asthma symptoms Inadequate use or response to asthma medications Allergen exposure, including dust mites, pet dander, mold, or pollen
Key Symptoms: Persistent coughing, especially at night or early morning Wheezing or a whistling sound during breathing Shortness of breath that occurs regularly Chest tightness or pressure Difficulty speaking due to shortness of breath Frequent respiratory infections or exacerbations requiring medical intervention Symptoms that interfere with daily activities or sleep
Diagnostic & Treatment
Diagnosis Path: Diagnosing severe persistent asthma involves a combination of medical history review, physical examinations, and lung function tests. Healthcare providers may perform spirometry to assess airflow obstruction and inflammation levels. Additionally, allergen testing and chest X-rays can help rule out other conditions and identify triggers that worsen asthma symptoms. Continuous monitoring helps to confirm the severity and guide appropriate treatment strategies.
Treatment Protocols: Managing severe persistent asthma usually requires a tailored approach, including medication and lifestyle adjustments, such as: - **Long-term control medications**, like inhaled corticosteroids to reduce airway inflammation. - **Combination inhalers** that include both corticosteroids and long-acting bronchodilators. - **Oral corticosteroids** for short periods during severe exacerbations. - **Leukotriene modifiers** to decrease inflammation and relieve symptoms. - **Biologic therapies** for patients unresponsive to conventional treatments, targeting specific immune pathways. - **Emergency medications**, such as short-acting beta-agonists, used as needed for quick relief. - Lifestyle modifications including avoiding known allergens, quitting smoking, and maintaining a healthy weight. Regular medical follow-up is essential to monitor lung function, medication effectiveness, and adjust the management plan as needed to keep symptoms under control and improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is J45.5 a billable ICD-10 code?
Yes, J45.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J45.5?
Clinical documentation must specify the nature of Severe persistent asthma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference